Microangiopathic haemolytic anaemia (MHA).
D000230:Adenocarcinoma / Q000097:blood; D000743:Anemia, Hemolytic / Q000188:drug therapy / Q000209:etiology*; D000818:Animals; D001777:Blood Coagulation; D004211:Disseminated Intravascular Coagulation / Q000150:complications; D004905:Erythrocyte Aging; D004913:Erythrocytes, Abnormal; D005340:Fibrinogen; D006463:Hemolytic-Uremic Syndrome / Q000097:blood; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006974:Hypertension, Malignant / Q000097:blood; D007457:Iodine Radioisotopes; D016030:Kidney Transplantation; D016031:Liver Transplantation; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood; D011817:Rabbits; D013925:Thromboplastin; D014184:Transplantation, Homologous; D014688:Venoms
D007457:Iodine Radioisotopes; D014688:Venoms; D005340:Fibrinogen; D006493:Heparin; D013925:Thromboplastin